Cognesy Therapeutics Announces Senior Leadership Team to Advance Neuroplasticity Drug Discovery Platform for Neuropsychiatric Disorders
LEXINGTON, Mass.–(BUSINESS WIRE)–Cognesy Therapeutics, a recently established company developing a platform for the discovery of neuroplasticity-inducing drugs to treat a wide range of neuropsychiatric disorders, announced appointments of its senior leadership team, the company said today. The company seeks to address the worldwide medical need for novel therapeutics to treat central nervous system diseases, such…